BUCOLO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 8.299
EU - Europa 4.557
AS - Asia 2.045
AF - Africa 437
SA - Sud America 84
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.443
Nazione #
US - Stati Uniti d'America 7.985
IT - Italia 1.667
IE - Irlanda 1.065
CN - Cina 1.000
UA - Ucraina 876
SG - Singapore 874
CA - Canada 303
CI - Costa d'Avorio 274
RU - Federazione Russa 256
DE - Germania 229
SN - Senegal 138
SE - Svezia 113
BR - Brasile 75
GB - Regno Unito 63
IN - India 55
FI - Finlandia 45
FR - Francia 45
CH - Svizzera 43
VN - Vietnam 33
BE - Belgio 27
NL - Olanda 26
UZ - Uzbekistan 19
GR - Grecia 18
NG - Nigeria 18
PL - Polonia 18
ES - Italia 17
AT - Austria 14
EU - Europa 10
AU - Australia 9
JP - Giappone 9
LB - Libano 9
CZ - Repubblica Ceca 8
HK - Hong Kong 8
MX - Messico 8
HR - Croazia 6
TR - Turchia 6
IL - Israele 5
CO - Colombia 4
IR - Iran 4
KR - Corea 4
PT - Portogallo 3
RO - Romania 3
ZA - Sudafrica 3
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BG - Bulgaria 2
DK - Danimarca 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
EC - Ecuador 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
VE - Venezuela 1
Totale 15.443
Città #
Santa Clara 1.513
Chandler 1.185
Dublin 1.058
Jacksonville 895
Singapore 590
Catania 539
Chicago 530
Boardman 458
Nanjing 299
Lawrence 288
Cambridge 282
Andover 279
Abidjan 274
Houston 244
Toronto 236
Ashburn 222
Des Moines 145
Dakar 138
San Mateo 131
Wilmington 122
Civitanova Marche 102
Grafing 85
Nanchang 79
Shenyang 71
Saint Petersburg 70
Hebei 67
Ottawa 66
Florence 64
Jiaxing 56
Bremen 55
Tianjin 49
Changsha 47
Rome 47
Messina 41
Redwood City 32
Los Angeles 31
Dong Ket 27
Falls Church 27
Moscow 27
Palermo 27
Seattle 26
Dearborn 25
Helsinki 25
Beijing 23
Pune 23
Hangzhou 22
Norwalk 22
Aci Catena 21
Brussels 21
Washington 21
Naples 20
Ningbo 20
Milan 19
Munich 19
Abuja 18
Jinan 18
Liberty Lake 18
Zhengzhou 18
Guangzhou 17
Lappeenranta 15
Lissone 15
Shanghai 15
Den Haag 14
Padova 13
Redmond 12
Ann Arbor 11
Reggio Calabria 11
Tappahannock 11
Boydton 10
Frankfurt Am Main 9
Hyderabad 9
Turin 9
Biancavilla 8
Kunming 8
Princeton 8
Ragusa 8
Siracusa 8
Warsaw 8
Casaleone 7
Mumbai 7
Napoli 7
Rosolini 7
San Francisco 7
Taizhou 7
Barcelona 6
Bronte 6
Canton 6
Fuzhou 6
Hanoi 6
Leawood 6
Mercogliano 6
New York 6
Stockholm 6
Amsterdam 5
Bangalore 5
Belo Horizonte 5
Bologna 5
Caltanissetta 5
Cork 5
Edinburgh 5
Totale 11.227
Nome #
Current drug treatments targeting dopamine D3 receptor 163
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 157
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 152
Dopaminergic-GABAergic interplay and alcohol binge drinking 143
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 140
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 117
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 116
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 109
Antioxidant and osmoprotecting activity of taurine in dry eye models 108
Design, Synthesis and Antiinflammatory Activity of Novel g-Tocopherol Acetylsalicylic acid Ester Codrug 107
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 104
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 98
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 98
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 97
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 96
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 92
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 91
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 90
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 89
Prognostic significance of deregulated microRNAs in uveal melanomas 88
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 87
Caffeine Protects Against Retinal Inflammation 85
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 85
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 85
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 81
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 80
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 79
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 79
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 78
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 78
P2X7 receptor antagonism: implications in diabetic retinopathy 77
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 76
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 74
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 73
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 72
Farmacologia Oculare 72
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 71
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 71
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 71
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 71
L'acido Ialuronico come Carrier Ideale nella Veicolazione Topica Oculare del Timololo 70
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 70
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes 69
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 69
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 68
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 68
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 67
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 67
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma 67
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 67
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 66
Valutazione del tempo di bioerosione di inserti intravitreali a base di esteri dell'acido ialuronico 65
Controversies in Glaucoma: Current Medical Treatment and Drug Development 65
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 65
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 65
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 65
Protective effects of a coumarin derivative in diabetic rats 64
COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING OCULAR INFLAMMATORY WITH LOWER RISK OF INCREASED INTRAOCULAR PRESSURE 64
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 64
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 63
Evaluation of tolerability of a series of lipoamino acids using biological membranes and a biomembrane model 63
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 63
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 63
Acidic mammalian chitinase in dry eye conditions 62
Ocular pharmacokinetics profile of different indomethacin topical formulations. 62
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 62
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 62
Novel therapeutics in glaucoma management 62
Rapid determination of nimesulide in rabbit aqueous humor by liquid chromatography 61
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 61
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 61
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats 61
Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit 61
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 60
Methylprednisolone delivery by Hyalobend corneal shields and its effects on rabbit ocular inflammation 60
A prolonged release polymeric nanocarrier for ocular administration 60
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 60
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 60
Retinal protection and distribution of curcumin in vitro and in vivo 60
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 60
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 59
Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation 59
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 59
Pharmacodynamic and pharmacokinetic profile of a new timolol/pilocarpine formulation 58
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 58
Lipoprotein(a) serum levels in diabetic patients with retinopathy 58
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients 58
Topical ophthalmic composition to reduce pain 58
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection 58
Fluoxetine Protects Retinal Ischemic Damage in Mice 57
Effects of hyaluronan on free-radical formation, corneal endothelium damage, and inflammation parameters after phacoemulsification in rabbits 57
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease 57
Enhanced ocular anti-inflammatory activity of lbuprofen carried by an Eudragit RS100((R)) nanoparticle suspension 57
Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells 57
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits 57
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 57
Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration 57
Protective effects of the sigma agonist Pre-084 in the rat retina 57
Gabapentin compositions for treating or preventing ocular pain 56
Ocular allergy 56
Totale 7.502
Categoria #
all - tutte 59.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 0 0 0 0 148 17 171 32 223 91
2020/20211.656 26 146 188 15 444 56 214 12 220 43 193 99
2021/20222.242 253 289 44 36 318 65 331 100 216 38 72 480
2022/20233.764 329 177 55 380 402 620 37 634 887 46 132 65
2023/20241.627 119 235 89 108 87 334 27 120 12 25 286 185
2024/20254.010 83 1.029 340 322 1.382 740 114 0 0 0 0 0
Totale 16.005